Microbix Biosystems Inc. is a Canada-based life science company. The Company is a manufacturer of viral and bacterial antigens and reagents for the diagnostics industry. The Company's segments include Virology Products and Technologies, Lumisort and Kinlytic. It is engaged in Virology Products business, which includes the manufacture and sale of cell culture-based biological products. It specializes in the research and development of biological solutions, including products for human health applications, primarily in the vaccine and therapeutic markets, as well as animal reproductive markets. It is also engaged in developing VIRUSMAX, which is a virus yield enhancement technology used to increase influenza vaccine manufacturing yields, and Kinlytic, a thrombolytic drug used to treat blood clots. It is involved in developing LumiSort, a semen sexing technology used in livestock industries. It owns and operates a virology manufacturing facility in Mississauga, Ontario.